Orion Sues Sun Pharma Global, Inc. in the U.S. to Enforce Orion's U.S. Patent No. 5,446,194 Covering its Proprietary Drug Comtan

Nov. 12, 2008--Orion Corporation filed a patent infringement lawsuit in the United States to enforce its U.S. Patent No. 5,446, against Sun Pharma, who seeks to market a generic version of Orion Corporation's proprietary drug, Comtan in the US. Comtan contains entacapone and is a product originated by Orion Corporation and marketed in the United States for the treatment of Parkinson's disease by its exclusive licensee, Novartis.

The details can be read here.